维普中文期刊产品整合服务
158篇 您的检索式:作者名="SAGA M"
    题名 作者 年代 出处 被引量
1Endoscopic ultrasound-guided vs endoscopic retrograde cholangiopancreatography biliary drainage for obstructed distal malignant biliary strictures: A systematic review and meta-analysis显示文摘BACKGROUND For palliation of malignant biliary obstruction(MBO), the gold-standard method of biliary drainage is endoscopic retrograde cholangiopancreatography(ERCP)with the placement of metallic stents. Endoscopic ultrasound(EUS)-guided drainage is an alternative that is typically reserved for cases of ERCP failure.Recently, however, there have been robust randomized clinical trials(RCTs)comparing EUS-guided drainage and ERCP as primary approaches to MBO.AIM To compare EUS guidance and ERCP in terms of their effectiveness and safety in palliative biliary drainage for MBO.METHODS This was a systematic review and meta-analysis, in which we searched the MEDLINE, Excerpta Medica, and Cochrane Central Register of Controlled Trials databases. Only RCTs comparing EUS and ERCP for primary drainage of MBO were eligible. All of the studies selected provided data regarding the rates of technical and clinical success, as well as the duration of the procedure, adverse events, and stent patency. We assessed the risk of biases using the Jadad score and the quality of evidence using the Grading of Recommendations Assessment,Development and Evaluation criteria.RESULTS The database searches yielded 5920 records, from which we selected 3 RCTs involving a total of 222 patients(112 submitted to EUS and 110 submitted to ERCP). In the EUS and ERCP groups, the rate of technical success was 91.96%n and 91.81%, respectively, with a risk difference(RD) of 0.00%(95%CI:-0.07, 0.07;P = 0.97; I^2 = 0%). The clinical success was 84.81% and 85.53% in the EUS and ERCP groups, respectively, with an RD of-0.01%(95%CI:-0.12, 0.10; P = 0.90; I^2 =0%). The mean difference(MD) for the duration of the procedure was-0.12%(95%CI:-8.20, 7.97; P = 0.98; I^2 = 84%). In the EUS and ERCP groups, there were14 and 25 adverse events, respectively, with an RD of-0.06%(95%CI:-0.23, 0.12; P= 0.54; I^2 = 77%). The MD for stent patency was 9.32%(95%CI:-4.53, 23.18; P =0.19; I^2 = 44%). The stent dysfunction rate was significantly lower in the EUS t group(MD =-0.22%; 95 CI:-0.35,-0.08; P = 0.001; I^2 = 0%).CONCLUSION EUS represents an interesting alternative to ERCP for MBO drainage,demonstrating lower stent dysfunction rates compared with ERCP. Technical and clinical success, duration, adverse events and patency rates were similar.Fernanda P Logiudice Wanderlei M Bernardo Facundo Galetti Vitor M Sagae Carolina O Matsubayashi Antonio C Madruga Neto Vitor O Brunaldi Diogo T H de Moura Tomazo Franzini Spencer Cheng Sergio E Matuguma Eduardo G H de Moura 2019World Journal of Gastrointestinal Endoscopy2019,11,4:6
2Two new lanostanoids from Ganoderma lucidum 显示文摘FUJITA A ARISAWA W SAGA M 1986J Nat Prod1986,49,6:1
3A novel homozygous Ile535Asn mutation in the rod cGMP phosphodiesterase beta-subunit gene in two brothers of a Japanese family with autosomal recessive retinitis pigmentosa显示文摘Saga M Mashima Y Akeo K 1998Curr Eye Res1998,17,3:1
4Three new lanostanoids from Ganoderma lucidum 显示文摘ARISAWA M FUJITA A SAGA M 1986J Nat Prod1986,49,4:1
5Overexpression of PTEN increases sensitivity to SN-38,an active metabolite of the topoisomerase I inhibitor irinotecan,in ovarian cancer cells显示文摘Saga Y Mizukami H Suzuki M 0,,:1
6In vivo genotoxicity of nrthu-phenylphenol, biphenyl, and thiabendazolc detected in multiple mouse organs by the alkaline single cell gel electrophore- sis assay显示文摘SASAKI YF SAGA A AKASAKA M 1997Murat Res1997,395,23:1
7Abnormal fragile histidine triad expression in advanced cervical cancer and evaluation of its utility as a prognostic factor显示文摘Machida S Ohwada M Saga Y 2003Oncol2003,65,1:1
8Distinct roles of Wnt/β-catenin and Bmp signaling during early cardiogenesis 显示文摘KLAUS A SAGA Y TAKETO M M 2007Proceedings of the National Academy of Sciences of the United States of America2007,104,18:1
9Two new lanostanoids from Ganoderma lucidum 显示文摘Fujita A Arisawa M Saga M 1986J Nat Prod1986,49,6:1
10DNA replication error is frequent in ovarian granulose cell tumors 显示文摘Suzuki M Ohwada M Saga Y 2000Cancer Genetics Cytogeneties2000,122,1:1
11Mechanisms of paelitaxel-induced apoptosis in an ovarian cancer cell line and its paelitaxel-resistant clone显示文摘Sugimura M Sagae S Ishioka S 2004Ontology2004,66,1:1
12In vitro fertilization (IVF) and artificial insemination (AI) by cryopreserved spermatozoa in mouse 显示文摘Okuyama M Isogai S Saga M 1990Fertil Implant1990,7,:1
13Establishment and characterization of a new cell line (SKS) from neuroendocrine small cell carcinoma of the uterine cervix and its chemosensitivity显示文摘Saga Y Suzuki M Tamura N 0,,04:1
14Mutation of K-RAS protooncogene and loss of heterozygosity on 6p27 in serous and mucinous ovarian carcinomas显示文摘 Saito S Saga Y 2000Cancer Genet Cytogenet2000,118,:1
15Mutation of the SRC gene in endometrial carcinoma显示文摘Sugimura M Kobayashi K Sagae S 2000Jpn J Cancer Res2000,91,4:1
16Molecular imaging of cancer: evaluating characters of individual Cancer by PET/SPECT imaging 显示文摘SAGA T KOIZUMI M FURUKAWA T 2009Cancer Sci2009,100,3:1
17Improved intratumoral penetration of radiolabeled streptavidin in intraperitoneal tumors pretargeted with biotinylated antibody显示文摘Zhang M Yao Z Saga T 1998J Nucl Med1998,39,1:1
18Scrotum exfoliative dermatit is with ulcers associated with treatment of acute promyelocytic leukemia with all-trans-retinoic acid显示文摘Tajima K Sagae M Yahagi A 1998R insho Ketsueki1998,39,1:1
19Detection of in vivo genotoxicity of haloalkanes and haloalkenes carcinogenic to rodents by the alkaline single cell gel electrophoresis (comet) assay in multiple mouse organs显示文摘SASAKI Y F SAGA A AKASAKA M 1998Mutat Res1998,419,13:1
20Blood pressure variability and organ damage in a general population : results from the PAME - LA study( Pression iArteriose Monitorate E Loro Association) 显示文摘Saga R Corrao G Bombelli M 2002Hy- pertension2002,39,22:1
返回顶部 每页显示:
共8页 首页 上一页 第1页 下一页 末页 /8 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费